Could a speedier insulin give teens with diabetes better control?
NCT ID NCT06948760
Summary
This small study tested if a faster-acting insulin (Lyumjev) works better in an automated insulin pump system for teenagers and young adults with type 1 diabetes. Researchers compared how well it kept blood sugar in a healthy range versus standard insulins (Humalog or Novolog). The goal was to see if using a special calculation to adjust the pump settings for the faster insulin improves daily diabetes management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.